Archive - March 2019
Novartis’ MS drug gets FDA approval
NICE recommendation for Steglatro in type II diabetes
FDA approves Novartis’ next-gen MS drug Mayzent
Genfit launches $135m IPO to back NASH plans
Trump takes aim at Obamacare with repeal move
Lilly and ImmuNext deal focused on autoimmune diseases
Avocado Nutrition Facts: Lowers Cholesterol And 5 Other Health Benefits
Is Oral Sex Healthy? 3 Dangers Of Fellatio